NCT00374179View on ClinicalTrials.gov

CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

February 28, 2009

Conditions
Cancer
Interventions
DRUG

CT-322

IV solution, weekly or bi-weekly

Trial Locations (3)

46202

Indiana University Cancer Center, Indianapolis

78229

South Texas Accelerated Research Therapeutics, San Antonio

78245-3217

Institute for Drug Development, San Antonio

All Listed Sponsors
lead

Adnexus, A Bristol-Myers Squibb R&D Company

INDUSTRY

NCT00374179 - CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter